Literature DB >> 25741396

Lipid Signaling in Tumorigenesis.

Renyan Liu1, Ying Huang1.   

Abstract

Lipids are important cellular building blocks and components of signaling cascades. Deregulation of lipid metabolism or signaling is frequently linked to a variety of human diseases such as diabetes, cardiovascular diseases, and cancer. It is widely believed that lipid molecules or their metabolic products are involved in tumorigenic inflammation and thus, lipids are implicated as significant contributors or even primary triggers of tumorigenesis. Lipids are believed to directly or indirectly activate growth promoting signals such as those involving LPA, insulin, IGF-1 and EGF to promote cancer cell growth. Cellular levels of certain lipids, including sphingosine-1-phosphate and ceramide, maintain a delicate balance between cell death and survival and alterations in their levels lead to unfavorable consequences including tumorigenesis. This article provides an overview of current knowledge that implicates lipids in tumorigenesis and explores the potential mechanisms that support a positive link between obesity and cancer.

Entities:  

Keywords:  Cancer; Ceramide; Lipid metabolism; Monoglyceride lipase; Obesity; Sphingosine-1-phosphate

Year:  2014        PMID: 25741396      PMCID: PMC4346139     

Source DB:  PubMed          Journal:  Mol Cell Pharmacol        ISSN: 1938-1247


  97 in total

1.  Mechanism of actin filament turnover by severing and nucleation at different concentrations of ADF/cofilin.

Authors:  Ernesto Andrianantoandro; Thomas D Pollard
Journal:  Mol Cell       Date:  2006-10-06       Impact factor: 17.970

Review 2.  Membrane recognition by phospholipid-binding domains.

Authors:  Mark A Lemmon
Journal:  Nat Rev Mol Cell Biol       Date:  2008-02       Impact factor: 94.444

3.  Involvement of insulin receptor substrate 2 in mammary tumor metastasis.

Authors:  Julie A Nagle; Zhefu Ma; Maura A Byrne; Morris F White; Leslie M Shaw
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

4.  A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer.

Authors:  Emily M Fox; Todd W Miller; Justin M Balko; Maria G Kuba; Violeta Sánchez; R Adam Smith; Shuying Liu; Ana María González-Angulo; Gordon B Mills; Fei Ye; Yu Shyr; H Charles Manning; Elizabeth Buck; Carlos L Arteaga
Journal:  Cancer Res       Date:  2011-09-09       Impact factor: 12.701

5.  A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer.

Authors:  Srinivasan Madhusudan; Martin Foster; Sethupathi R Muthuramalingam; Jeremy P Braybrooke; Susan Wilner; Kulwinder Kaur; Cheng Han; Susan Hoare; Frances Balkwill; Denis C Talbot; Trivadi S Ganesan; Adrian L Harris
Journal:  Clin Cancer Res       Date:  2004-10-01       Impact factor: 12.531

6.  Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.

Authors:  Boryana K Popivanova; Kazuya Kitamura; Yu Wu; Toshikazu Kondo; Takashi Kagaya; Shiuchi Kaneko; Masanobu Oshima; Chifumi Fujii; Naofumi Mukaida
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

Review 7.  The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment.

Authors:  Alexander Greenhough; Helena J M Smartt; Amy E Moore; Heather R Roberts; Ann C Williams; Christos Paraskeva; Abderrahmane Kaidi
Journal:  Carcinogenesis       Date:  2009-01-09       Impact factor: 4.944

Review 8.  Treatment of inflammatory diseases by selective eicosanoid inhibition: a double-edged sword?

Authors:  Saul Yedgar; Miron Krimsky; Yuval Cohen; Roderick J Flower
Journal:  Trends Pharmacol Sci       Date:  2007-08-10       Impact factor: 14.819

9.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

10.  Potential tumor-suppressive role of monoglyceride lipase in human colorectal cancer.

Authors:  H Sun; L Jiang; X Luo; W Jin; Q He; J An; K Lui; J Shi; R Rong; W Su; C Lucchesi; Y Liu; M S Sheikh; Y Huang
Journal:  Oncogene       Date:  2012-02-20       Impact factor: 9.867

View more
  5 in total

1.  Being Overweight or Obese Increases the Risk of Progression in Triple-Negative Breast Cancer after Surgical Resection.

Authors:  Yunseon Choi; Sung Kwang Park; Ki Jung Ahn; Heunglae Cho; Tae Hyun Kim; Hye Kyoung Yoon; Yun-Han Lee
Journal:  J Korean Med Sci       Date:  2016-04-22       Impact factor: 2.153

2.  Association between obesity and local control of advanced rectal cancer after combined surgery and radiotherapy.

Authors:  Yunseon Choi; Yun-Han Lee; Sung Kwang Park; Heunglae Cho; Ki Jung Ahn
Journal:  Radiat Oncol J       Date:  2016-06-17

Review 3.  A novel approach to the discovery of anti-tumor pharmaceuticals: searching for activators of liponecrosis.

Authors:  Anthony Arlia-Ciommo; Veronika Svistkova; Sadaf Mohtashami; Vladimir I Titorenko
Journal:  Oncotarget       Date:  2016-02-02

4.  Transcriptomic reappraisal identifies MGLL overexpression as an unfavorable prognosticator in primary gastrointestinal stromal tumors.

Authors:  Chien-Feng Li; I-Chieh Chuang; Ting-Ting Liu; Ko-Chin Chen; Yen-Yang Chen; Fu-Min Fang; Shau-Hsuan Li; Tzu-Ju Chen; Shih-Chen Yu; Jui Lan; Hsuan-Ying Huang
Journal:  Oncotarget       Date:  2016-08-02

5.  Hydroxysteroid 11-Beta Dehydrogenase 1 Overexpression with Copy-Number Gain and Missense Mutations in Primary Gastrointestinal Stromal Tumors.

Authors:  Chien-Feng Li; Ting-Ting Liu; Jui-Chu Wang; Shih-Chen Yu; Yen-Yang Chen; Fu-Min Fang; Wan-Shan Li; Hsuan-Ying Huang
Journal:  J Clin Med       Date:  2018-11-01       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.